Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment
- 18 August 2023
- journal article
- editorial
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 82 (6) , 729-731
Abstract
No abstract availableFunding Information
- National Institute of Child Health and Human Development
- National Football League Foundation
- National Institutes of Health
- NICHD (5K23HD102555)
This publication has 15 references indexed in Scilit:
- Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II studyStroke and Vascular Neurology, 2021
- Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic StrokeJAMA, 2020
- MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetNew England Journal of Medicine, 2018
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3)International Journal of Stroke, 2017
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Treatment Decisions After Severe StrokeStroke, 2012
- Phase IIB/III Trial of Tenecteplase in Acute Ischemic StrokeStroke, 2010
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995